| univariabel | multivariabel | ||||
---|---|---|---|---|---|---|
beta | 95% CI | p-value | beta | 95% CI | p-value | |
Gender (male) | 1.97 | [–1.35, 5.28] | 0.244 | 2.75 | [0.096, 5.40] | 0.042 |
Profession | Â | Â | <0.001* | Â | Â | <0.001* |
Physician as reference: | ||||||
 Nurse Practitioner | 4.19 | [0.38, 8.01] | 0.031* | 3,2 | [–0.43, 6.83] | 0.084 |
 Nurse | –1.60 | [–4.80, 1.59] | 0.324 | –0,54 | [–3,64, 2.55] | 0.729 |
 Pharmacist | –12.69 | [–16.04,–9.34] | <0.001* | –10,9 | [–14.2,–7.72] | < 0.001 |
Work experience (yr) | –0.03 | [–0.17, 0.11] | 0.673 |  |  |  |
Type of hospital (academic) | –3.20 | [–6.45, 0.06] | 0.054 |  |  |  |
Specialisation (oncology) | –2.36 | [–5.80, 1.09] | 0.178 |  |  |  |
Country (the Netherlands) | –2.51 | [5.50, 0.48] | 0.100 | –3,51 | [–5.81,–1.21] | 0.003* |
Adherence (PAMQs) | ||||||
 Insight in adherence | 6.80 | [3.93, 9.68] | <0.001* |  |  |  |
 Patients’ communication | 9.32 | [6.62, 12.01] | <0.001* |  |  |  |
 Capability to influence | 5.78 | [2.08, 9.47] | 0.002* |  |  |  |
 Knowledge of consequences | 3.60 | [–0.04, 7.24] | 0.053 |  |  |  |
 Insight in causes | 3.70 | [0.59, 6.81] | 0.020* |  |  |  |
 PAMQs sum score | 3.23 | [2.26, 4.19] | <0.001* | 2,26 | [1.41, 3.11] | <0.001* |
SDM scorea | –0.00 | [–0.09, 0.09] | 0.973 |  |  |  |
BMQ-Specific | ||||||
 Necessity | –0.15 | [–0.65, 0.36] | 0.565 |  |  |  |
 Concerns | –0.074 | [–6.94, 0.55] | 0.814 |  |  |  |
 N-C differential | –0.07 | [–0.48, 0.35] | 0.753 |  |  |  |
BMQ-group | Â | Â | 0.972 | Â | Â | Â |
Accepting as reference: | ||||||
 Ambivalent | –3.34 | [–3.72, 3.05] | 0.844 |  |  |  |
 Indifferent | 0.32 | [–5.45, 6.08] | 0.866 |  |  |  |
 Sceptical | –2.22 | [–12.55, 8.11] | 0.680 |  |  |  |